Document:

pri-ex44_789.htm

EXHIBIT 4.4

DESCRIPTION OF REGISTRANT’S SECURITIES

REGISTERED PURSUANT TO SECTION 12 OF THE

SECURITIES EXCHANGE ACT OF 1934

 

The following description sets forth certain material terms and provisions of the securities of Primerica, Inc. (the “company,” “we,” “us” and “our”) that are registered under Section 12 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). This description also summarizes relevant provisions of Delaware General Corporation Law (the “DGCL”). The following summary does not purport to be complete and is subject to, and is qualified in its entirety by reference to, the applicable provisions of the DGCL and our certificate of incorporation and our by-laws, copies of which are incorporated by reference as an exhibit to the Annual Report on Form 10-K of which this Exhibit 4.4 is a part. We encourage you to read our certificate of incorporation, our by-laws and the applicable provisions of the DGCL for additional information.

Authorized Shares of Capital Stock 

 

Our authorized capital stock consists of 500,000,000 shares of common stock, par value $0.01 per share, comprised of a series of voting common stock and a series of non-voting common stock, and 10,000,000 shares of preferred stock, par value $0.01 per share. As of January 31, 2020, we had 41,108,029 shares of voting common stock outstanding and no shares of non-voting common stock or preferred stock outstanding. The outstanding shares of our common stock are fully paid and non-assessable.

 

Common Stock

 

Voting Rights. Holders of our voting common stock are entitled to one vote per share on all matters submitted to a vote of stockholders. Holders of our non-voting common stock are not entitled to vote on any matter, except as required by law or to amend, alter or repeal the provisions of our certificate of incorporation providing for the preferences, limitations and rights of the non-voting common stock.  Holders of our common stock do not have cumulative voting rights.  

 

Dividend Rights.  Holders of our voting common stock and non-voting common stock rank equally with respect to payment of dividends, as may be declared by our board of directors out of funds legally available for the payment of those dividends. 

 

Rights Upon Liquidation.  Upon the liquidation, dissolution or winding up of our company, the holders of our voting common stock and non-voting common stock will rank equally and will be entitled to receive their ratable share of our net assets available after payment of all debts and other liabilities, subject to the prior rights of any outstanding preferred stock. 

 

Other Rights and Procedures.  Holders of our voting common stock and non-voting common stock have no preemptive, subscription or redemption rights. 

 

Listing.  Our common stock has been approved for listing on the NYSE under the symbol “PRI”. 

 

Transfer Agent and Registrar.  The Transfer Agent and Registrar for our voting common stock and non-voting common stock is Computershare Inc.

 

 

Preferred Stock 

Our board of directors has the authority, without any further vote or action by the stockholders, to issue preferred stock in one or more series and to fix the preferences, limitations and rights of the shares of each series, including: 

	
 
	
•
	
dividend rates; 

	
 
	
•
	
conversion rights; 

	
 
	
•
	
voting rights; 

	
 
	
•
	
terms of redemption and liquidation preferences; and 

	
 
	
•
	
the number of shares constituting each series. 

Board of Directors

Our board of directors is not classified. Our certificate of incorporation provides that our board of directors shall consist of not less than three or more than fifteen members, the exact number of which shall be fixed from time to time by resolution adopted by the affirmative vote of a majority of the entire board of directors which we would have if there were no vacancies at the time such resolution is adopted. This range cannot be altered without stockholder approval.

Anti-Takeover Effect of Provisions of Our Certificate of Incorporation and By-laws and of Delaware Law

The rights of our stockholders and related matters are governed by the DGCL, our certificate of incorporation and by-laws, certain provisions of which may discourage or make more difficult a takeover attempt that a stockholder might consider in his or her best interest by means of a tender offer or proxy contest or removal of our incumbent officers or directors. These provisions may also adversely affect prevailing market prices for our common stock. However, we believe that these provisions will discourage coercive takeover practices and inadequate takeover bids and will encourage persons seeking to acquire control of our company to first negotiate with our board of directors. We further believe that the benefits provided by our ability to negotiate with the proponent of an unsolicited proposal outweigh the disadvantage of discouraging those proposals and that negotiation of an unsolicited proposal could result in an improvement of its terms. 

 

Certificate of Incorporation and By-law Provisions

 

Stockholder Action by Written Consent; Special Meetings.  Our certificate of incorporation permits stockholders to take action by the written consent of holders of all of our shares in lieu of an annual or special meeting. Otherwise, stockholders will only be able to take action at an annual or special meeting called in accordance with our by-laws. 

 

Our by-laws provide that special meetings of stockholders may only be called by: 

 

	
 
	
•
	
the chairman of the board;

 

	
 
	
•
	
the chief executive officer; or

 

2

 

	
 
	
•
	
by request in writing of our board of directors or of a committee of our board of directors that has been duly designated by our board of directors and whose powers and authority include the power to call such meetings. 

 

Advance Notice Requirements for Stockholder Nominations and Other Proposals.  Our by-laws provide advance notice requirements, including requirements regarding the form and content of a stockholder’s notice, for stockholders seeking to nominate persons for election to our board of directors at a meeting of stockholders or seeking to bring other business before such a meeting. A stockholder seeking to do either of the foregoing must satisfy the requirements specified in our by-laws.

 

Proxy Access.  Under our by-laws, a stockholder (or group of no more than 20 stockholders) who has owned at least 3% of our common stock for at least three years may nominate persons for election to our board of directors and have the nominees included in our proxy materials for an annual meeting. The maximum number of stockholder nominees that will be included in our proxy materials for an annual meeting is the greater of two or 20% of directors to be elected. A stockholder seeking to utilize the proxy access provisions in our by-laws must satisfy the requirements specified in our by-laws.

 

Undesignated Preferred Stock.  The authority possessed by our board of directors to issue preferred stock with voting or other rights or preferences could be potentially used to discourage attempts by third parties to obtain control of us through a merger, tender offer, proxy contest or otherwise by making such attempts more difficult or more costly. The provision in our certificate of incorporation authorizing such preferred stock may have the effect of deferring hostile takeovers or delaying changes of control of our management. 

 

Amendment of the By-laws.  Our certificate of incorporation provides that our by-laws may be amended, altered, repealed or adopted by: (i) the affirmative vote of at least 66 2/3% of our entire board of directors; or (ii) by the affirmative vote of at least 80% of the votes entitled to be cast thereon by the holders of our then outstanding capital stock. Our certificate of incorporation provides that, notwithstanding any other provision thereof (and in addition to any other vote that may be required by law), the affirmative vote of at least 80% of the votes entitled to be cast thereon by the holders of our then outstanding capital stock is required to amend, alter, repeal or adopt any provision of our certificate of incorporation inconsistent with the purpose and intent of the provisions described in this paragraph.

 

Delaware Law

 

As a Delaware corporation, we are subject to the restrictions under Section 203 of the DGCL regarding corporate takeovers. In general, Section 203 prohibits a publicly-held Delaware corporation from engaging, under certain circumstances, in a business combination with an interested stockholder for a period of three years following the date the person became an interested stockholder, unless: 

 

	
 
	
•
	
prior to the date of the transaction, the board of directors of the corporation approved either the business combination or the transaction which resulted in the stockholder becoming an interested stockholder; 

 

	
 
	
•
	
upon completion of the transaction that resulted in the stockholder becoming an interested stockholder, the interested stockholder owned at least 85% of the voting stock of the corporation outstanding at the time such transaction commenced, excluding, for purposes of determining the number of shares outstanding, (1) shares owned by persons who are directors and also officers of the corporation and (2) shares owned by employee stock plans in which employee participants do not have the right to determine confidentially whether shares held subject to the plan will be tendered in a tender or exchange offer; or 

3

 

 

	
 
	
•
	
on or subsequent to the date of the transaction, the business combination is approved by the board of directors of the corporation and authorized at an annual or special meeting of stockholders by the affirmative vote of at least 66 2/3% of the outstanding voting stock which is not wholly owned by the interested stockholder.

 

In this context, a business combination includes a merger, asset or stock sale, or other transaction resulting in a financial benefit to the interested stockholder. An interested stockholder is a person who, together with affiliates and associates, owns or, within three years prior to the determination of interested stockholder status owned, 15% or more of a corporation’s outstanding voting stock. 

 

A Delaware corporation may “opt out” of Section 203 with an express provision in its original certificate of incorporation or an express provision in its certificate of incorporation or bylaws resulting from amendments approved by holders of at least a majority of the corporation’s outstanding voting shares. We have not elected to “opt out” of Section 203. However, we may elect to “opt out” of Section 203 by an amendment to our certificate of incorporation or by-laws. 

Insurance Regulations Concerning Change of Control

 

Many state insurance regulatory laws intended primarily for the protection of policyholders contain provisions that require advance approval by state agencies of any change in control of an insurance company or insurance holding company that is domiciled or, in some cases, having such substantial business that it is deemed to be commercially domiciled in that state. Moreover, under Canadian federal insurance law, the consent of the Minister of Finance is required in order for anyone to acquire direct or indirect control, including control in fact, of an insurance company, or to acquire, directly or through any controlled entity or entities, a significant interest (i.e., more than 10%) of any class of its shares. 

Limitation of Liability of Directors 

 

Our certificate of incorporation provides that none of our directors shall be liable to us or our stockholders for monetary damages for any breach of fiduciary duty as a director, except to the extent otherwise required by the DGCL. The effect of this provision is to eliminate our rights, and our stockholders’ rights, to recover monetary damages against a director for breach of a fiduciary duty of care as a director. This provision does not limit or eliminate our right, or the right of any stockholder, to seek non-monetary relief, such as an injunction or rescission in the event of a breach of a director’s duty of care. In addition, our certificate of incorporation provides that if the DGCL is amended to authorize the further elimination or limitation of the liability of a director, then the liability of the directors shall be eliminated or limited to the fullest extent permitted by the DGCL, as so amended. These provisions will not alter the liability of directors under federal or state securities laws. Our certificate of incorporation also includes provisions for the indemnification of our directors and officers to the fullest extent permitted by Section 145 of the DGCL. Further, we have entered into indemnification agreements with our directors and executive officers which require us, among other things, to indemnify them against certain liabilities which may arise by reason of their status or service as a director or officer and to advance to them expenses, subject to reimbursement to us if it is determined that they are not entitled to indemnification. We also have obtained director and officer liability insurance. 

4

 

Choice of Forum

 

Our certificate of incorporation provides that, unless the company (through approval of the board of directors) consents in writing to the selection of an alternative forum, the Court of Chancery of the State of Delaware shall be the sole and exclusive forum for (i) any actual or purported derivative action or proceeding brought on our behalf; (ii) any action asserting a claim of breach of a fiduciary duty owed by any director or officer to us or our stockholders; (iii) any action asserting a claim arising pursuant to any provision of the DGCL; or (iv) any action asserting a claim governed by the internal affairs doctrine.

 

5pri-ex1019_760.htm

EXHIBIT 10.19

EXECUTION VERSION

 

NOVATION AMENDMENT

 

THIS NOVATION AMENDMENT (the "Novation Amendment") is made as of December 15, 2016, by and among PRIMERICA LIFE INSURANCE COMPANY OF CANADA ("Primerica"), MUNICH RE LIFE INSURANCE COMPANY OF VERMONT ("Munich Re

Vermont"), and MUNICH RE OF MALTA P.L.C. ("Munich Re Malta").

 

WHEREAS, Munich American Holding Company ("MAHC") acquired all of the issued and outstanding shares of Financial Reassurance Company 2010, Ltd. from Citigroup Insurance Holding Corporation on September 23, 2016 and changed the name the company to Munich Re Life Insurance Company of Vermont; and

 

WHEREAS, Primerica and Munich Re Vermont previously entered into the Coinsurance Agreement, as amended, effective March 31, 2010 (hereinafter "Coinsurance Agreement") attached hereto in Appendix A, whereby Primerica cedes and Munich Re Vermont reinsures certain life insurance business pursuant to the terms of the Coinsurance Agreement; and

 

WHEREAS, Munich Re Malta is an affiliate of MAHC and Munich Re Vermont; and

 

WHEREAS, Primerica, Munich Re Vermont and Munich Re Malta have agreed to effectuate the novation of the Coinsurance Agreement by substituting Munich Re Vermont with Munich Re Malta as the counterparty to Primerica under the Coinsurance Agreement as set forth below, such that all of Munich Re Vermont's rights, liabilities and obligations under the Coinsurance Agreement shall be solely, directly and exclusively transferred and novated to Munich Re Malta and Munich Re Vermont will be fully and unconditionally released from all liabilities or obligations under the Coinsurance Agreement, except as provided herein; and

 

WHEREAS, contemporaneously with the transactions contemplated in this Novation Amendment, Munich Re Vermont is assigning, transferring and conveying to Munich Re Malta all of Munich Re Vermont's rights, title, interest, duties, liabilities and obligations under that certain Reinsurance Security Agreement, dated December 31, 2011, among Primerica, Munich Re Vermont and RBC Investor Services Trust; and

WHEREAS, immediately following the novation of the Coinsurance Agreement from Munich Re Vermont to Munich Re Malta pursuant to this Novation Amendment, Primerica and Munich Re Malta desire to amend the Coinsurance Agreement to make such other amendments as are set forth in this Novation Amendment; and

WHEREAS, (i) Primerica, Munich Re Vermont and Munich Re Malta wish to consent and agree to such novation and (ii) Primerica and Munich Re Malta wish to consent and agree to such amendment to the Coinsurance Agreement; and

WHEREAS, all capitalized terms not otherwise defined here shall have the meanings ascribed to them in the Coinsurance Agreement.

 

 

 

 

NOW   THEREFORE IN CONSIDERATION OF the mutual covenants and agreements hereinafter set forth, the parties hereto agree as follows:

 

I) Munich Re Vermont hereby transfers and assigns to Munich Re Malta, and Munich Re Malta hereby assumes all past, present and future interests, rights, title, duties, obligations, responsibilities, claims, demands, actions, causes of actions, judgments, liabilities, proceedings and costs, including reasonable attorney's fees and other costs of defense and damages of Munich Re Vermont (whether known or unknown and whether existing now or arising hereafter with respect to periods on, before or after the date hereof) under the Coinsurance Agreement; provided, that Munich Re Malta's agreement to perform such duties, obligations and liabilities shall be subject to any and all defenses, setoffs or counterclaims to which Munich Re Vermont would be entitled with respect to the Coinsurance Agreement, and no such defenses, setoffs or counterclaims are waived by this Novation Amendment or the consummation of the transactions contemplated hereby. Munich Re Malta agrees that Primerica shall be entitled vis-a-vis Munich Re Malta to any and all defenses, setoffs or counterclaims to which Primerica would,  prior to the entering into of this Novation Amendment, have been entitled  vis-a-vis  Munich Re Vermont with respect to the Coinsurance Agreement, and  no such defenses,  setoffs or counterclaims are waived by this Novation Amendment or the consummation of the transactions contemplated hereby.

	
 
	
2)
	
The parties hereby acknowledge and agree that the transfer and assignment of the Coinsurance Agreement from Munich Re Vermont to Munich Re Malta hereunder constitutes a novation of the Coinsurance Agreement, with the effect that Munich Re Malta shall replace Munich Re Vermont under the Coinsurance Agreement in  all respects and shall be bound by all of the terms and conditions of the Coinsurance Agreement as if Munich Re Malta were the original party thereunder.
	
 

 

	
 
	
3)
	
Primerica hereby consents and agrees to the novation of the Coinsurance Agreement. Primerica fully and unconditionally releases and forever discharges Munich Re Vermont from all of its past, present and future duties, obligations and liabilities, and all claims, demands and causes of action arising under or in respect of the Coinsurance Agreement (whether known or unknown and whether existing now or arising hereafter with respect to periods on, before or after the date hereof), provided that, notwithstanding any other provisions of this Novation Amendment, Munich Re Vermont is not released from, and shall continue to be bound by, its obligations under Section 21.10 of the Coinsurance Agreement.
	
 

	
 
	
4)
	
Primerica agrees that the transfer, assignment and novation of the Coinsurance Agreement shall have the force and effect of creating a direct agreement between Primerica and Munich Re Malta. From and after the date hereof, Primerica shall not look to Munich Re Vermont and instead shall look only to Munich Re Malta with respect to any rights it may have under the Coinsurance Agreement (whether such rights arise or relate to periods prior to or after the date hereof). Primerica acknowledges and agrees that any failure on the part of Munich Re Malta to perform under the Coinsurance Agreement shall not result in any liability to Munich Re Vermont. Primerica further agrees that, from and after the date hereof, it shall perform any and all of its obligations
	
 

 

 

 

and duties under the Coinsurance Agreement for the benefit of Munich Re Malta and pay any amounts owing under the Coinsurance Agreement to Munich Re Malta (in each case whether such obligations, duties and payments were or are attributable to or accrue or accrued prior to or after the date hereof).

 

	
 
	
5)
	
The Coinsurance Agreement is hereby amended by deleting the name of Munich Re Vermont wherever it appears and substituting therefore the name of Munich Re Malta.
	
 

 

	
 
	
6)
	
Amendments to Definitions.The following definitions in the Coinsurance Agreement are amended as follows:
	
 

 

	
 
	
(a)
	
Business Day. Section 1.1(t) of the Coinsurance Agreement is hereby amended and restated to read as follows:
	
 

 

"Business Day" means any day other than a day on which banks in the Province of Ontario or Malta are permitted or required to be closed.

 

	
 
	
(b)
	
Custodian. Section 1.1(j.1) of the Coinsurance Agreement is hereby amended by deleting the reference to "RBC Investors Services Limited" and replacing it with a reference to the "RBC Investor Services Trust".
	
 

 

	
 
	
(c)
	
MCCSR Guideline.Section 1.1 (gg) of the Coinsurance Agreement is hereby deleted in its entirety and replaced with the following:
	
 

 

(gg) "MCCSR Guideline" means Guideline A - entitled "Minimum Continuing Capital and Surplus Requirements" dated November 2015.

 

	
 
	
(d)
	
Required Balance.Section l.l(jjj) of the Coinsurance Agreement is hereby deleted in its entirety and replaced with the following:
	
 

 

"Required Balance" means, (i) for any date prior to January 1, 2020, the greater of (a) and (b), and (ii) for any date on or after January 1, 2020, 110% of the greater of(a) and (b) where,

	
 
	
(a)
	
is the Reinsurer's Quota Share of the Subject Reserves with respect to the Reinsured Policies, and
	
 

	
 
	
(b)
	
is the amount of assets necessary at any particular point in time under the MCCSR Guideline in order for the Ceding Company to take full Financial Statement Credit for the unlicensed reinsurance in the same manner as if licensed reinsurance was being provided that enables the Ceding Company to maintain its OSFI target capital ratio as well as to be able to meet all Dynamic Capital Adequacy Testing adverse scenarios that  may  be required by OSFI with respect to the Reinsurer's Quota Share of  the Subject Reserves.
	
 

 

	
 
	
(e)
	
Vermont Regulator. Section l.1(vvv) of the Coinsurance Agreement is hereby deleted in its entirety and replaced with the following:
	
 

 

 

 

(vvv) "Malta Regulator" means the Malta Financial Services Authority which is responsible for the licensure and ongoing supervision of the Reinsurer.

 

	
 
	
(±)
	
New defined terms.Section 1.1 of the Coinsurance Agreement 1s hereby amended by adding the following new defined terms:
	
 

 

"Novation Amendment" means the Novation Amendment, dated as of December 15, 2016, entered into by and among the Reinsurer, Munich Re Life Insurance Company of Vermont, and the Reinsurer.

 

	
 
	
7)
	
Recapture Events. Section 11.1(b) and (c) of the Coinsurance Agreement are hereby amended by deleting each reference to "Vermont Regulator" and replacing it with a reference to "Malta Regulator".
	
 

 

	
 
	
8)
	
Jurisdiction for Dispute Resolution. Section 14.1 of the Coinsurance Agreement is hereby amended by deleting the reference to "the State of Vermont" and replacing it with a reference to "Malta."
	
 

 

	
 
	
9)
	
Adjustment of Collaterals and Withdrawals. Section 15.J(c) of the Coinsurance Agreement is hereby deleted in its entirety and replaced with the following:
	
 

(c) If the Reinsurance Security Account Balance exceeds the Required  Balance  as defined in Section 1.1(jjj)(ii) (meaning, for greater certainty, 110% of the greater of paragraphs (a) and (b) in Section 1.1(jjj)(ii)), as of the end of the immediately preceding calendar quarter, then the Reinsurer shall have the right to seek approval from the Ceding Company (which shall not be unreasonably or arbitrarily withheld, conditioned or delayed) to withdraw excess Collateral, provided that the amount of such withdrawal of excess Collateral would not reduce the Securities Account Balance to less than Required Balance as defined in Section 1.1(jjj)(ii), as of the end of the immediately preceding month, and if so approved, such excess shall be withdrawn in accordance with the Reinsurance Security Agreement.

	
 
	
10)
	
 Jurisdiction of Organization. Section 17.J(a) of the Coinsurance Agreement is hereby amended by deleting the phrase "special purpose financial captive insurance company duly organized, validly existing and in good standing under the laws of the State of Vermont' and replacing it with the following phrase: "reinsurance company duly organized, validly existing and in good standing under the laws of Malta."
	
 

	
 
	
11)
	
Address for Notice to Munich Re Malta. Section 21.5 of the Coinsurance Agreement is hereby amended by deleting the address for notice for the Reinsurer and replacing it with the following:
	
 

 

Chief Underwriting Officer Munich Re of Malta p.l.c.

Level 4, Whitehall Mansions, Ta Xbiex XBX I026, Malta

 

 

 

 

 

With copies to (which shall not constitute notice to the Reinsurer for the purposes of Section 21.5):

 

Chief Financial Officer Chief Risk Officer Munich Re Centre

390 Bay Street, 26th floor Toronto, Ontario M5H 2Y2

 

	
 
	
12)
	
In all other respects, the terms of the Coinsurance Agreement shall remain unaltered and shall remain in full force and effect, it being understood that Primerica and Munich Re Malta may subsequently amend the Coinsurance Agreement.
	
 

 

	
 
	
13)
	
Primerica and Munich Re Malta hereby ratify and confirm the Coinsurance Agreement as an agreement solely among them.
	
 

 

	
 
	
14)
	
Each party hereto agrees to take all such actions and execute and deliver all such documents, certificates, instruments and conveyances as may be necessary or desirable to carry out and give full effect to this Novation Amendment.
	
 

 

	
 
	
15)
	
This Novation Amendment shall inure to the benefit of and be binding upon the parties hereto and their respective successors and assigns. Unless otherwise provided herein, neither party may assign any of its rights, remedies, interests, powers or privileges, or delegate any of its duties or obligations, hereunder without the prior written consent of the other party, which consent shall not be unreasonably withheld, conditioned or delayed. Nothing in this Novation Amendment is intended to give any person, other than the parties hereto and their respective successors and assigns, any legal or equitable right, remedy or claim under or in respect of this Novation Amendment or any provision contained herein.
	
 

	
 
	
16)
	
If any provision of this Novation Amendment is held to be invalid or unenforceable in whole or in part, such invalidity or unenforceability shall attach only to such provision or part thereof and the remaining part of such provision and all other provisions hereof shall continue in full force and effect.  In the event of the invalidity  or unenforceability of any term or provision of this Novation Amendment, the parties hereto shall use their commercially reasonable efforts to reform such terms or provisions to carry out the commercial intent of the parties hereto as reflected herein, while curing the circumstance giving rise to the invalidity or unenforceability of such term or provision.
	
 

 

	
 
	
17)
	
This Novation Amendment shall be governed by, interpreted and enforced in accordance with the laws of the Province of Ontario and the federal laws of Canada applicable therein.
	
 

	
 
	
18)
	
This Novation Amendment may be signed in counterparts, and each counterpart shall constitute an original document, and such counterparts, taken together, shall constitute one and the same instrument.
	
 

 

 

 

 

[Signature page follows.]

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

IN WITNESS WHEREOF the parties have executed this Novation Amendment as of the dates below.

 

 

 

 

PRIMERICA LIFE INSRUANCE COMPANY OF CANADA

By: /s/ John AdamsBy: /s/ Heather Koski Title:  CEOTitle: Senior Vice President, Finance and CFO Date: December 16, 2016Date: December 16, 2016 

MUNICH RE LIFE INSURANCE COMPANY OF VERMONT

By: /s/ Bernard NaumannBy: /s/ Paige Freeman Title: PresidentTitle: Secretary Date: December 16, 2016Date: December 15, 2016 MUNICH RE OF MALTA P.L.C.

By: /s/ Peter MiehleBy: /s/ Birger Schimpf

	
 
	
Title: Chief Executive Officer
	
Title: Chief Underwriting Officer Date:  December 15, 2016Date: December 15, 2016
	
 

 

 

 

Appendix A

Coinsurance Agreement

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00305-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00305-of-00352.parquet"}]]